Covid-19: PM Modi to virtually interact with 3 teams of vaccine developers

Expressing pride in the fact that India's indigenous vaccine development has progressed at such a rapid pace so far, he had stressed that India considers vaccines as not only vital to good health but also as a global good, and it is India's duty to assist other countries, including the nations in the neighbourhood, in the collective fight against the virus.

Modi asked the scientists to express their free and frank opinion on how the country could further improve its regulatory process. The scientists also presented an overview of how they are also developing various new and repurposed drugs to better fight Covid-19.

After visiting Pune, the Prime Minister had tweeted, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."

The Covidshield vaccine is being developed jointly by Oxford University, AstraZeneca and the SII, which is the world's largest vaccine manufacturer.

Currently, the SII is producing around 50-60 million doses which would be scaled up to to 100 million by January 2021, SII CEO Adar Poonawalla told the media.

Also Read: COVID vaccine maker AstraZeneca targeted by suspected North Korean hackers